Empirical antifungal therapy - New options, new tradeoffs

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)278-280
Number of pages3
JournalNew England Journal of Medicine
Volume346
Issue number4
DOIs
StatePublished - Jan 24 2002
Externally publishedYes

Fingerprint

Pyrimidines
Triazoles
Mycoses
Antifungal Agents
Amphotericin B
Neutropenia
Fever
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Empirical antifungal therapy - New options, new tradeoffs. / Marr, Kieren.

In: New England Journal of Medicine, Vol. 346, No. 4, 24.01.2002, p. 278-280.

Research output: Contribution to journalArticle

@article{7f6d239e43bc45c5bc9c3e520e3221d3,
title = "Empirical antifungal therapy - New options, new tradeoffs",
author = "Kieren Marr",
year = "2002",
month = "1",
day = "24",
doi = "10.1056/NEJM200201243460410",
language = "English (US)",
volume = "346",
pages = "278--280",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - Empirical antifungal therapy - New options, new tradeoffs

AU - Marr, Kieren

PY - 2002/1/24

Y1 - 2002/1/24

UR - http://www.scopus.com/inward/record.url?scp=0037165256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037165256&partnerID=8YFLogxK

U2 - 10.1056/NEJM200201243460410

DO - 10.1056/NEJM200201243460410

M3 - Article

C2 - 11807153

AN - SCOPUS:0037165256

VL - 346

SP - 278

EP - 280

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 4

ER -